Back to Search
GAIL PRENDERGAST, M.D.
M.D.
Hospitalist Physician
NPI: 1548294184Individual
Specialties, Licenses & Credentials
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
036102246(IL)036-102246(IL)
Research & Publications (20)
Signal transduction: putting translation before transcription.
PMID 14585349·Cancer Cell·2003
6-review
Farnesyltransferase inhibitors define a role for RhoB in controlling neoplastic pathophysiology.
PMID 11193202·Histol Histopathol·2001
6-review
Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects.
PMID 10712917·Curr Opin Cell Biol·2000
7-preclinical
The relative magnitude of the effects of biological and physical settlement cues for cypris larvae of the acorn barnacle, Semibalanus balanoides L.
PMID 18846458·Biofouling·2009
7-preclinical
Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target.
PMID 19476837·J Am Coll Surg·2009
8-other
The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity.
PMID 19494274·J Immunol·2009
7-preclinical
BAR the door: cancer suppression by amphiphysin-like genes.
PMID 18930786·Biochim Biophys Acta·2009
6-review
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.
PMID 18364004·Immunol Rev·2008
6-review
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
PMID 18665584·J Med Chem·2008
8-other
Field-based video observations of wild barnacle cyprid behaviour in response to textural and chemical settlement cues.
PMID 18696291·Biofouling·2008
7-preclinical
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
PMID 18026137·Oncogene·2008
7-preclinical
A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation.
PMID 18806825·Oncogene·2008
8-other
Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging.
PMID 18339847·Cancer Res·2008
7-preclinical
Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer.
PMID 18237448·BMC Med Genomics·2008
8-other
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
PMID 18318466·J Med Chem·2008
7-preclinical
Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration.
PMID 18180298·J Biol Chem·2008
7-preclinical
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
PMID 18952840·Proc Natl Acad Sci U S A·2008
7-preclinical
Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
PMID 19004406·J Reprod Med·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 403 E. 1ST STREET, KATHERINE SHAW BETHEA HOSPITAL
DIXON, IL 61021 - Phone
- (815) 285-5629
Quick Facts
- NPI
- 1548294184
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile